Clinical Trials in Salt Lake City

Showing 3361-3380 of 14,325 trials

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

NCT06208878

This study will evaluate the long-term safety and efficacy of CRISPR CAR T cellular therapies

CRISPR Therapeutics AG70 participantsStarted Nov 2023

Duarte, California, United States • Los Angeles, California, United States • Stanford, California, United States +19 more locations

Active Not RecruitingNA< 1 mile

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

NCT05796453

The purpose of this Post-Market Clinical Follow-up study is to describe the long-term safety and performance of the Clareon Vivity and Vivity Toric and Clareon PanOptix and PanOptix Toric IOLs.

AphakiaAstigmatismPresbyopia

Alcon Research470 participantsStarted Sep 2023

Torrance, California, United States • Jacksonville, Florida, United States • Liverpool, New York, United States +4 more locations

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix

Find Trials by Condition in Salt Lake City

Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)

Air Optix Plus HydraGlyde Multifocal Daily/Extended Wear Contact Lenses

Ropeginterferon Alfa-2b (P1101) vs. Anagrelide in Essential Thrombocythemia Patients With Hydroxyurea Resistance or Intolerance

A Study to Evaluate the Efficacy and Safety of 2 Doses of EYE103 Compared With Ranibizumab (0.5 mg) in Participants With DME

Role of Multimodal Analgesia in Decreasing Perioperative Pain in Tibial Plateau Fractures

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy

A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022)

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

Long Term Extension Study of Tapinarof Cream, 1% for Subjects With Atopic Dermatitis

A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

Expanded Access of Sotorasib

A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer

Assessment of the GORE® EXCLUDER® Conformable AAA Endoprosthesis in the Treatment of Abdominal Aortic Aneurysms

Nonalcoholic Fatty Liver Disease (NAFLD) Database 3

The MOOD Study - External Combined Occipital and Trigeminal Nerve Stimulation (eCOT-NS) for the Treatment of Major Depressive Disorder (MDD)

Cessation of Somatostatin Analogues After PRRT in Mid, Hind-Gut and Pancreatic Neuroendocrine Tumours